No Data
No Data
Monopar Therapeutics Shares Jump After First Patient Dosed in Cancer Therapy
Express News | Monopar Announces First Patient Dosed With Its Novel Therapeutic Radiopharmaceutical Mnpr-101-Lu
Monopar Announces First Patient Dosed With Its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference
Express News | Monopar Therapeutics Files Prospectus Relates to Resale From Time to Time of up to 705,015 Shares of Common Stock by Selling Stockholder
JonesTrading Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Raises Target Price to $37